The GCK (Germinal Center Kinase) Group III family of kinases falls under the larger Ste20 (sterile 20) superfamily of serine/threonine kinases. This group is characterized by a distinct structural and functional profile, setting it apart within the Ste20 kinase superfamily. The Ste20 family itself is quite large, encompassing a broad array of kinases implicated in various cellular signaling pathways. These pathways are crucial for controlling a range of cellular functions, including cell growth, differentiation, death, and volume regulation. In humans, about 30 members of the Ste20 family have been identified, and the GCK Group III kinases are a notable subset of this family.
Small molecule inhibitors targeting the Ste20 (sterile 20) superfamily of serine/threonine kinases are designed to modulate the kinase activity of this diverse group of enzymes. The Ste20 family plays a pivotal role in a variety of cellular signaling pathways, influencing processes such as cell growth, differentiation, apoptosis, and cytoskeletal organization. By inhibiting these kinases, small molecules can alter the phosphorylation state of target proteins, thereby modulating the signaling pathways in which these kinases are involved. The specificity and efficacy of these inhibitors are crucial, as they need to selectively target the Ste20 kinases without affecting other serine/threonine kinases.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | ¥2775.00 | 10 | |
Staurosporine 的衍生物,可抑制蛋白激酶 C,促进细胞周期停滞。 | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | ¥1061.00 ¥3926.00 | 69 | |
AMPK 抑制剂可能会通过能量感应途径的反馈回路间接影响 STK 的表达或活性。 | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | ¥2877.00 ¥12083.00 | 4 | |
针对 STK 家族 AKT 同工酶的泛 AKT 抑制剂。 | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | ¥1579.00 | ||
钙/钙调蛋白依赖性蛋白激酶激酶(CaMKK)的抑制剂,可能会间接影响 STK。 | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | ¥1805.00 ¥3892.00 | 12 | |
mTOR 激酶的选择性抑制剂,是 PI3K/AKT/mTOR 通路的一部分。 | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | ¥2708.00 | 7 | |
强效、选择性 mTOR 抑制剂,作用于 mTORC1 和 mTORC2。 | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | ¥733.00 ¥2369.00 | 26 | |
葡萄糖类似物和糖酵解抑制剂可能会通过改变细胞能量状态来影响 STK 的表达。 | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | ¥124.00 ¥192.00 ¥1218.00 ¥2764.00 ¥10357.00 ¥553.00 | 33 | |
一种黄酮类化合物,已知可影响多种信号通路;它对 STK 的影响可能是间接的,并取决于具体情况。 | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | ¥440.00 ¥1015.00 | 212 | |
ERK 抑制剂可能会通过 MAPK 信号通路调节 STK 的表达或活性。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | ¥1681.00 ¥5303.00 ¥6995.00 ¥13527.00 ¥23579.00 | 33 | |
组蛋白去乙酰化酶(HDAC)抑制因子,有可能通过调节基因转录动态来影响 STK 的表达。 |